THIS EXHIBIT HAS BEEN REDACTED TO REMOVE INFORMATION THAT IS NOT MATERIAL AND THAT THE REGISTRANT MUST TREAT AS PRIVATE AND CONFIDENTIAL.** FELICITEX MATERIAL TRANSFER AGREEMENTFelicitex Material Transfer Agreement • September 16th, 2022 • Felicitex Therapeutics Inc. • Pharmaceutical preparations • Massachusetts
This Felicitex Material Transfer Agreement (this “Agreement”) is dated July 18, 2022 and is by and between Felicitex Therapeutics, Inc., a Delaware corporation, located at 27 Strathmore Rd, Natick, MA 01760 (“‘Felicitex”) and Barbara Ann Karmanos Cancer Institute, a Michigan nonprofit corporation, located at 4100 John R, Detroit, MI 48201 (“Recipient”) (together with Felicitex, “Parties” and each, a “Party”).
FELICITEX MATERIAL TRANSFER AGREEMENTFelicitex Material Transfer Agreement • August 10th, 2022 • Felicitex Therapeutics Inc. • Pharmaceutical preparations • Massachusetts
This Felicitex Material Transfer Agreement (this “Agreement”) is dated May 15th, 2021 and is by and between Felicitex Therapeutics, Inc., a Delaware corporation (“Felicitex”) at 27 Strathmore Rd., Natick, MA, USA and UAB DolceRx Baltika (“DolceRx”), a Lithuanian corporation (“Recipient”) at Pramones str. 21, Klaipeda, Lithuania (together with Felicitex, “Parties” and each, a “Party”).
